Clinical Trial Update: Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing nilotinib to imatinib in adults with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase was terminated, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)
• Tasigna (nilotinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Myelogenous Leukemia | Phase 3 | Status: TERMINATED | Results posted: 2011-05-10